Luye Pharma Group Ltd Total Liabilities

Latest as of December 2025: €14.47 Billion EUR ≈ $16.91 Billion USD

Luye Pharma Group Ltd total liabilities. Based on the latest financial reports, Luye Pharma Group Ltd (LUP) has total liabilities worth €14.47 Billion EUR (≈ $16.91 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Luye Pharma Group Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Luye Pharma Group Ltd (2016–2025)

Total liabilities of Luye Pharma Group Ltd from 2016 to 2025. This chart illustrates how Luye Pharma Group Ltd's total liabilities have evolved over time, based on quarterly financial data.

Luye Pharma Group Ltd Competitors by Total Liabilities

The table below lists competitors of Luye Pharma Group Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Guangzhou Risong Intelligent Technology Holding Co Ltd SHG:688090	China	CN¥940.80 Million
Hunan New Wellful Co Ltd SHG:600975	China	CN¥8.74 Billion
ASRock Inc TW:3515	Taiwan	NT$14.38 Billion
Nuveen Select Tax-Free Income Portfolio NYSE:NXP	USA	$44.19 Million
Zhejiang Kaier New Materials SHE:300234	China	CN¥191.97 Million
Hainan Development Holdings Nanhai Co Ltd SHE:002163	China	CN¥4.96 Billion
Cimsa Cimento Sanayi ve Ticaret AS IS:CIMSA	Turkey	TL43.23 Billion
Bangkok Chain Hospital Public Company Limited BK:BCH	Thailand	฿3.28 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Luye Pharma Group Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Luye Pharma Group Ltd's balance sheet.

Liquidity & Leverage Metrics

Luye Pharma Group Ltd Total Liabilities Ratios Explained

Luye Pharma Group Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.53	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.90	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.44	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Luye Pharma Group Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Luye Pharma Group Ltd (2016–2025)

The table below shows the annual total liabilities of Luye Pharma Group Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€14.47 Billion ≈ $16.91 Billion	+4.39%
2024-12-31	€13.86 Billion ≈ $16.20 Billion	+15.85%
2023-12-31	€11.96 Billion ≈ $13.99 Billion	-9.43%
2022-12-31	€13.21 Billion ≈ $15.44 Billion	-1.93%
2021-12-31	€13.47 Billion ≈ $15.75 Billion	+7.47%
2020-12-31	€12.53 Billion ≈ $14.65 Billion	+26.05%
2019-12-31	€9.94 Billion ≈ $11.62 Billion	+3.51%
2018-12-31	€9.60 Billion ≈ $11.23 Billion	+148.54%
2017-12-31	€3.86 Billion ≈ $4.52 Billion	+46.17%
2016-12-31	€2.64 Billion ≈ $3.09 Billion	--

About Luye Pharma Group Ltd

F:LUP Germany Drug Manufacturers - Specialty & Generic

Market Cap

$840.60 Million

€719.01 Million EUR

Market Cap Rank

#9339 Global

#1184 in Germany

Share Price

€0.18

Change (1 day)

+1.12%

52-Week Range

€0.18 - €0.35

All Time High

€0.70